No Title of Publication Journal Name Delete link
1 Complications management in liver transplantation
PDF icon 2018_complications_management_-_copy.pdf
The 11th Liver Update And The Scientific Meeting of INA AL/PPHI In Conjunction with The 7 th CISHMS 2018
2 Evaluation of HCV RNA Viral Load With Using Genexpert
PDF icon 2018_evaluation_of_hcv_rna_viral_load_-_copy.pdf
The 11th Liver Update And The Scientific Meeting of INA AL/PPHI In Conjunction with The 7 th CISHMS 2018
3 Association Between SNP IL-28B and Sustained Virological Response and Its Relation with Expression of Interferon Lambda and Interferon Lambda Receptor in Liver Tissues of Chronic Hepatitis C Patients Treated with Pegylated Interferon-A2 and Ribaviri
PDF icon 2015_association_between_snp_il-28b_and.pdf
Prosiding : The 8th Liver Update and the22nd 2015
4 The Important Role of CD4+ Cells Intrahepatic in Liver Damage of HCV-HIV Co-infection Patients
PDF icon The Important Role of CD4+ Cells Intrahepatic in Liver Damage of HCV-HIV Co-infection Patients
Prosiding : The 8th Liver Update and the22nd Scientific Meeting of INA ASL/PPHI 2015
5 OBESITY AND LIVER CANCER
PDF icon 2015_obesity_and_liver_cancer.pdf
Prosiding : The 8th Liver Update and the22nd 2015
6 WHAT WE HAVE LEARNED? THE EVOLUTION OF HBV TREATMENT
PDF icon 2015_what_we_have_learned.pdf
Prosiding : The 8th Liver Update and the22nd 2015
7 MANAGEMENT OF RESISTANCE AND SIDE EFFECTS ON LONG-TERM ANTIVIRAL THERAPY
PDF icon 2015_management_of_resistance_and_side.pdf
Prosiding : The 8th Liver Update and the22nd 2015
8 LOW GENETIC BARRIER NUC: DON’T USE IT
PDF icon 2016_low_genetic_barrier_nuc.pdf
Prosiding : The 9th Liver Update 2016
9 INTERPRETATION AND EVALUATION OF LIVER ENZYMES IN COMMUNITY: DOES IT ENOUGH TO PREVENT DISEASE PROGRESSION?
PDF icon 2016_interpretation_and_evaluation_of_liver.pdf
Prosiding : The 9th Liver Update 2016
10 CHALLENGING TREATMENT OF CHRONIC HEPATITIS C INFECTION IN SPECIAL POPULATION
PDF icon 2016_challenging_treatment.pdf
Prosiding : The 9th Liver Update 2016
11 Hepatitis Virus Management Before & after liver transplantation
PDF icon 2016_hepatitis_virus_management.pdf
Prosiding : The 9th Liver Update 2016
12 The Role Of Liver Biopsy In Non Invasiveere
PDF icon 2016_the_role_of_liver_biopsy.pdf
Prosiding : The 9th Liver Update 2016
13 1.34 case reports : radiation-induced hepatitis b virus reactivation in HBSAG negative patient
PDF icon 1.34 case reports : radiation-induced hepatitis b virus reactivation in HBSAG negative patient
LIVER UPDATE 2017
14 1.33 case reports : refractory chylous ascites as a clinical manifestation of para aortic non-hodgkin lymphoma
PDF icon 1.33 case reports : refractory chylous ascites as a clinical manifestation of para aortic non-hodgkin lymphoma
LIVER UPDATE 2017
15 1.32 Treatment of intermediate-stage hepatocellular carcinoma : current practice and outcome in tertiary hospitals
PDF icon 1.32 Treatment of intermediate-stage hepatocellular carcinoma : current practice and outcome in tertiary hospitals
LIVER UPDATE 2017
16 1.23 Elevated pretreatment neutrophil-to-lymphocyte ratio is associated with child-pugh C class and high alpha-fetoprotein level in hepatocellular carcinoma patients
PDF icon 1.23 Elevated pretreatment neutrophil-to-lymphocyte ratio is associated with child-pugh C class and high alpha-fetoprotein level
APASL 2017 CHINA
17 1.22 Effectiveness of generic sofosbufir plus ribavirin or sofosbufir plus pegylated interferon and ribavirin for chronis hepatitis C patients in Indonesia : Real Life Experience
PDF icon 1.22 Effectiveness of generic sofosbufir plus ribavirin or sofosbufir plus pegylated interferon and ribavirin for chronis hepati
APASL 2017 CHINA
18 1.16 Survival Rate of HCC Patients After Fifteen Years in A Tertiary Referral Hospital In Indonesia
PDF icon 1.16 Survival Rate of HCC Patients After Fifteen Years in A Tertiary Referral Hospital In Indonesia
LIVER UPDATE 2016
19 1.15 Factors that Predict Pretreatment and on-treatment SVR in CHC Patients Treated with Dual Therapy in Indonesian
PDF icon 1.15 Factors that Predict Pretreatment and on-treatment SVR in CHC Patients Treated with Dual Therapy in Indonesian
APASL 2016 TOKYO
20 1.13 Treatment associated factors in HCV/HIV coinfected patients with peginterferon and ribavirin in indonesia
PDF icon 1.13 Treatment associated factors in HCV/HIV coinfected patients with peginterferon and ribavirin in indonesia
APASL STC NEW DELHI 2015
21 Role of expression of interferon lambda and their receptor in liver tissues in the mechanism of SNP IL-28B on sustaines virological response of hepatitis C patients treates with pegylates interferon alpha2 and ibavirin
PDF icon Role of expression of interferon lambda and their receptor in liver tissues in the mechanism of SNP IL-28B on sustaines virologi
APASL STC NEW DELHI 2015
22 KAJIAN MUTASI GEN POLIMERASE VIRUS HEPATITIS B MENGGUNAKAN METODE DIRECT SEQUENCING PADA SAMPEL PASIEN PENDERITA HEPATITIS B KRONIK YANG DIOBATI DENGAN ANALOG NUKLEOSIDA DI RUMAH SAKIT DR. CIPTO MANGUNKUSUMO JAKARTA
PDF icon KAJIAN MUTASI GEN POLIMERASE VIRUS HEPATITIS B MENGGUNAKAN METODE DIRECT SEQUENCING PADA SAMPEL PASIEN PENDERITA HEPATITIS B KRO
POSTER LIVER UPDATE 2015
23 Role of vascular endothelial growth factor as a predictor of six-month survival rate in patients
PDF icon Role of vascular endothelial growth factor as a predictor of six-month survival rate in patients
APASL 2015 Istanbul
24 Clinical Significance of Intrahepatic HBsAg Quantification in Correlation with Quantitative HBsAg Serum in Chronic Hepatitis B Patients Who Received Oral Antiviral Therapy
PDF icon Clinical Significance of Intrahepatic HBsAg Quantification in Correlation with Quantitative HBsAg Serum in Chronic Hepatitis B P
APDW 2014
25 Comparison between Viral Load, qHBsAg, and Aspartate-Platelet Ratio Index with Metavir Scoring of Chronic Hepatitis B Patients in Indonesia
PDF icon Comparison between Viral Load, qHBsAg, and Aspartate-Platelet Ratio Index with Metavir Scoring of Chronic Hepatitis B Patients i
APASL LIVER WEEK 2013 SINGAPORE
26 Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single-center experience
PDF icon Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pan
JGH Open: An open access journal of gastroenterology and hepatology 2 (2018) 4 – 7
27 Survival analysis in patients with malignant obstructive jaundice underwent biliary drainage procedure
PDF icon Survival analysis in patients with malignant obstructive jaundice underwent biliary drainage procedure
Hepatol Int (2017) 11 (Suppl 1):S1–S1093
28 Clinical presentations and treatment modalities of hepatocellular Carcinoma Associated with viral hepatitis and Non Viral Liver Diseases
PDF icon Clinical presentations and treatment modalities of hepatocellular Carcinoma Associated with viral hepatitis and Non Viral L
Hepatol Int (2017) 11 (Suppl 1):S1–S1093
29 Pegylated-Interferon Ribavirin as HCV-HIV Co-Infection Treatment in DAA Non-Affordable Country
PDF icon Pegylated-Interferon Ribavirin as HCV-HIV Co-Infection Treatment in DAA Non-Affordable Country
Hepatol Int (2017) 11 (Suppl 1):S1–S1093
30 Impact of oral antiviral therapy cessation after long term treatment
PDF icon Impact of oral antiviral therapy cessation after long term treatment
Naskah Lengkap Liver Update 2016
31 Outcome of hepatitis B long-life treatment in Indonesia
PDF icon Outcome of hepatitis B long-life treatment in Indonesia
Naskah Lengkap Liver Update tahun 2017
32 Chronic Hepatitis C From Basic to Common Practice
PDF icon Chronic Hepatitis C From Basic to Common Practice
Naskah Lengkap Liver Update tahun 2017
33 Therapeutic result using generic DAA in Indonesia
PDF icon Therapeutic result using generic DAA in Indonesia
Naskah Lengkap Liver Update tahun 2017